Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia

Clinical trial NCT00919958 · COMPLETED

Trial details

NCT number: NCT00919958
Sponsor: Pluristem Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Peripheral Artery Disease Peripheral Vascular Disease Critical Limb Ischemia

Start date: 2009-06-01
Primary completion: 2012-06-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.